TFS CAPITAL LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 100 filers reported holding ARATANA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$381,000
-78.9%
53,001
-72.5%
0.10%
-76.4%
Q3 2016$1,805,000
+1862.0%
192,848
+1230.8%
0.43%
+2441.2%
Q2 2016$92,000
-68.3%
14,491
-72.4%
0.02%
-59.5%
Q1 2016$290,000
-28.0%
52,518
-27.3%
0.04%
-2.3%
Q4 2015$403,000
-47.2%
72,266
+47.8%
0.04%
-28.3%
Q2 2014$763,000
+142.2%
48,883
+188.1%
0.06%
+185.7%
Q1 2014$315,00016,9670.02%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,184,942$31,784,0004.70%
AWM Investment Company, Inc. 1,562,517$9,578,0001.67%
Opaleye Management Inc. 420,000$2,574,0000.91%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0000.75%
GENERAL AMERICAN INVESTORS CO INC 867,600$5,318,0000.50%
Grandeur Peak Global Advisors, LLC 538,363$3,300,0000.50%
Redmond Asset Management, LLC 55,941$343,0000.16%
WOODSTOCK CORP 88,303$541,0000.10%
CADENCE CAPITAL MANAGEMENT LLC 173,808$1,065,0000.07%
Sheaff Brock Investment Advisors, LLC 71,000$435,0000.06%
View complete list of ARATANA THERAPEUTICS INC shareholders